- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 489/06 - Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
Patent holdings for IPC class C07D 489/06
Total number of patents in this class: 17
10-year publication summary
|
3
|
5
|
4
|
2
|
0
|
1
|
0
|
2
|
0
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Progenics Pharmaceuticals, Inc. | 123 |
3 |
| Board of Regents, The University of Texas System | 6225 |
1 |
| The Board of Regents of the University of Oklahoma | 671 |
1 |
| Cody Laboratories, Inc. | 6 |
1 |
| Florida Atlantic University Board of Trustees | 111 |
1 |
| Southern Research Institute | 203 |
1 |
| Taiwanj Pharmaceuticals Co., Ltd. | 19 |
1 |
| University of Cincinnati | 935 |
1 |
| University of Tsukuba | 639 |
1 |
| Virginia Commonwealth University | 671 |
1 |
| Serturner Corp. | 6 |
1 |
| Tactus Therapeutics, Inc. | 1 |
1 |
| Halda Therapeutics OpCo, Inc. | 44 |
1 |
| Humanwell Pharmaceutical US | 5 |
1 |
| Antheia, Inc. | 6 |
1 |
| Other owners | 0 |